SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067701
Filing Date
2014-11-13
Accepted
2014-11-13 16:00:56
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v393070_10q.htm 10-Q 379616
2 EXHIBIT 31.1 v393070_ex31-1.htm EX-31.1 10481
3 EXHIBIT 31.2 v393070_ex31-2.htm EX-31.2 10502
4 EXHIBIT 32.1 v393070_ex32-1.htm EX-32.1 4497
5 EXHIBIT 32.2 v393070_ex32-2.htm EX-32.2 4639
  Complete submission text file 0001144204-14-067701.txt   3507452

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20140930.xml EX-101.INS 462209
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20140930.xsd EX-101.SCH 35126
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20140930_cal.xml EX-101.CAL 27454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20140930_def.xml EX-101.DEF 173706
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20140930_lab.xml EX-101.LAB 254458
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20140930_pre.xml EX-101.PRE 202661
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 141218340
SIC: 2834 Pharmaceutical Preparations